OMX Copenhagen PI
1.136,59
PKT
-22,62
PKT
-1,95
%
Werbung
Analysen zu OMX Copenhagen PI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 28.02.22 | Novo Nordisk Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 15.02.22 | Novo Nordisk Overweight | Barclays Capital | |
| 08.02.22 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
| 07.02.22 | Novo Nordisk Hold | Deutsche Bank AG | |
| 03.02.22 | Novo Nordisk Neutral | UBS AG | |
| 03.02.22 | Novo Nordisk Outperform | Bernstein Research | |
| 03.02.22 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
| 03.02.22 | Novo Nordisk Hold | Deutsche Bank AG | |
| 03.02.22 | Novo Nordisk Neutral | Credit Suisse Group | |
| 02.02.22 | Novo Nordisk Outperform | Bernstein Research | |
| 02.02.22 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 02.02.22 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 02.02.22 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
| 01.02.22 | A.P. Moeller - Maersk A-S (B) Neutral | Goldman Sachs Group Inc. | |
| 31.01.22 | Novo Nordisk Overweight | Barclays Capital | |
| 26.01.22 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
| 26.01.22 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 25.01.22 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
| 24.01.22 | Novo Nordisk Outperform | Bernstein Research | |
| 18.01.22 | A.P. Moeller - Maersk A-S (B) Buy | Deutsche Bank AG | |
| 06.01.22 | Novo Nordisk Hold | Deutsche Bank AG | |
| 06.01.22 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 04.01.22 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
| 04.01.22 | Novo Nordisk Outperform | Bernstein Research | |
| 21.12.21 | Novo Nordisk Hold | Kepler Cheuvreux | |
| 21.12.21 | Novo Nordisk Overweight | Barclays Capital | |
| 20.12.21 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
| 07.12.21 | Novo Nordisk Buy | Deutsche Bank AG | |
| 07.12.21 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 29.11.21 | Novo Nordisk Buy | Deutsche Bank AG | |
| 29.11.21 | A.P. Moeller - Maersk A-S (B) Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 26.11.21 | Novo Nordisk Neutral | UBS AG | |
| 26.11.21 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 26.11.21 | Novo Nordisk Outperform | Bernstein Research | |
| 22.11.21 | Novo Nordisk Overweight | Barclays Capital | |
| 19.11.21 | Novo Nordisk Neutral | UBS AG | |
| 18.11.21 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 15.11.21 | A.P. Moeller - Maersk A-S (B) Neutral | JP Morgan Chase & Co. | |
| 11.11.21 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 04.11.21 | Novo Nordisk Neutral | Credit Suisse Group |